Using the same EIA commercial kit (Phoenix Pharmaceuticals), we found that elevated visfatin levels were associated with a higher prevalence of type 2 diabetes mellitus just in obese subjects. This evidence concerns the gene NAMPT and type 2 diabetes mellitus.